ArticleHeart rhythm O22025
Real-time magnetic resonance-guided radiofrequency ablation and lesion evaluation in an magnetic resonance-compatible isolated beating pig heart platform.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Interventional cardiovascular magnetic resonance imaging (MRI) offers real-time, radiation-free guidance for complex procedures such as myocardial ablation, marking a promising advance in electrophysiology. However, further development is limited by challenges in magnetic resonance (MR)-compatible instrument testing, MRI sequence validation, and accurate correlation with histopathology, hindered by the limitations of in vivo tissue evaluation. Objective: This study investigated the feasibility of real-time MR-guided radiofrequency (RF) ablation in an MR-compatible isolated beating pig heart platform and characterized ablation lesions using MRI and histopathology. Methods: A heart from a pig slaughtered for human consumption was prepared under regulatory guidelines and connected to a custom-built, MR-compatible perfusion platform supporting left ventricular function in both Langendorff and working modes. Autologous heparinized blood circulated at physiological pressures and temperatures. MR-guided catheter navigation and RF ablation were performed on a Philips 3T scanner using active catheter tracking. Native T1 and T2 mapping were acquired before and after ablation. Lesions were confirmed by histologic analysis. Results: RF ablation (50 W, 60 seconds) was successfully performed at 5 left ventricular sites. MRI showed focal reductions in T1 (936 ± 80 ms) surrounded by elevated T1 (1357 ± 18 ms) and T2 values (86 ± 10 ms) compared with nonablated myocardium (T1 1192 ± 26 ms; T2 66 ± 6 ms), consistent with necrosis and edema. Histology confirmed a necrotic core with a surrounding rim showing contraction band necrosis and erythrocyte extravasation. Conclusion: This study demonstrates the feasibility of real-time MR-guided ablation in a beating pig heart platform. The setup allows high-resolution lesion assessment and histologic correlation, supporting future developments in MR-guided therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.